Putting an end to hospital-borne infection with micronebulisation of lung-safe disinfectants

通过对肺部安全的消毒剂进行微雾化来消除医院传播的感染

• 批准号: LP140100416
• 负责人: Prof Leslie Yeo
• 金额: $ 22.99万
• 依托单位: RMIT University
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-11-12 至 2018-11-11
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP140100416
• 关键词: Putting; end; hospital; borne; infection

Dangerous infections are unfortunately common in hospitals, established and retransmitted via surfaces and handheld items, representing a leading contributor to death worldwide, and potentially a far more serious problem to come as antimicrobial resistance worsens. The project aims to exploit a newly discovered and unique low power nebulisation technology to nebulise a strongly antiviral, antibacterial and antifungal agent, triethylene glycol that is too viscous to do so by any other known method. Through refinement and engineering of the technology via this project, handheld and room-based continuously operating nebulisers will produce continuous microdroplet mists of these pathogen-killing agents that deposit on surfaces throughout a hospital.

不幸的是，危险感染在医院中很常见，通过表面和手持物品建立并重新传播，是全球死亡的主要原因，并且随着抗菌素耐药性的恶化，可能会成为一个更严重的问题。该项目旨在利用一种新发现的独特的低功率雾化技术来雾化一种强抗病毒、抗菌和抗真菌的药物——三甘醇，这种药物太粘稠，无法通过任何其他已知的方法来实现。通过本项目的技术改进和工程设计，手持和室内连续操作的雾化器将产生连续的微液滴雾，这些微液滴雾会沉积在整个医院的表面上。